JHH-7Homo sapiens (Human)Cancer cell line

Also known as: Functional Liver Cell-7, FLC7, FLC-7, JHH7, Jhh-7

🤖 AI SummaryBased on 10 publications

Quick Overview

Human hepatocellular carcinoma cell line with metastatic potential.

Detailed Summary

JHH-7 is a human hepatocellular carcinoma (HCC) cell line derived from liver tissue. It is characterized by its ability to invade through reconstituted extracellular matrix (ECM) when stimulated by hepatocyte growth factor (HGF). This cell line expresses u-PA but not MT1-MMP in vitro, yet HGF induces MT1-MMP expression and enhances invasiveness. JHH-7 tumors in vivo show MT1-MMP expression, indicating the influence of host factors on its metastatic potential. The cell line is used in studies investigating the role of MT1-MMP in HCC invasion and metastasis, as well as the effects of HGF on tumor progression. Additionally, JHH-7 is part of comprehensive cancer cell line databases, contributing to research on genetic diversity and therapeutic targeting in HCC.

Research Applications

Invasion and metastasis studiesMT1-MMP and HGF signalingDrug response profilingGenetic diversity in HCC

Key Characteristics

Invasive potential in vivoHGF-induced MT1-MMP expressionu-PA expression without MT1-MMPMetastatic tumor formation in vivo
Generated on 6/19/2025

Basic Information

Database IDCVCL_2805
SpeciesHomo sapiens (Human)

Donor Information

Age53
Age CategoryAdult
SexMale
Raceasian

Disease Information

DiseaseAdult hepatocellular carcinoma
LineageLiver
SubtypeHepatocellular Carcinoma
OncoTree CodeHCC

DepMap Information

Source TypeHSRRB
Source IDACH-000848_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Arg267Pro (c.800G>C)Unspecified-PubMed=24662767
MutationSimpleTERTc.1-124C>T (c.228C>T) (C228T)UnspecifiedIn promoterfrom parent cell line Hep-G2

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
13,14
D13S317
12
D16S539
13
D18S51
17
D21S11
29,33.2
D3S1358
15,17
D5S818
13
D7S820
8,11
D8S1179
10,11
FGA
22
Penta D
12
Penta E
10,11
TH01
6
TPOX
9,11
vWA
16,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

A pharmacogenomic landscape in human liver cancers.";

Hui L.-J.

Cancer Cell 36:179-193.e11(2019).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

Analysis of liver cancer cell lines identifies agents with likely efficacy against hepatocellular carcinoma and markers of response.

Couchy G., Calderaro J., Nault J.-C., Zucman-Rossi J., Rebouissou S.

Gastroenterology 157:760-776(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Screening for 15 pathogenic viruses in human cell lines registered at the JCRB Cell Bank: characterization of in vitro human cells by viral infection.

Satoh M., Shimizu N., Kohara A.

R. Soc. Open Sci. 5:172472-172472(2018).

Characterization of human cancer cell lines by reverse-phase protein arrays.

Liang H.

Cancer Cell 31:225-239(2017).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.

Xu J.-C.

Hepatology 58:706-717(2013).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

A comprehensive gene expression analysis of human hepatocellular carcinoma cell lines as components of a bioartificial liver using a radial flow bioreactor.

Kosuge M., Takizawa H., Maehashi H., Matsuura T., Matsufuji S.

Liver Int. 27:101-108(2007).

Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase.

Nagamori S., Yamada Y., Saiki I.

Neoplasia 1:424-430(1999).

Yeast functional assay of the p53 gene status in 11 cell lines and 26 surgical specimens of human hepatocellular carcinoma.

Gao C., Ohashi R., Pu H., Inoue Y., Tsuji T., Miyazaki M., Namba M.

Oncol. Rep. 6:1267-1271(1999).

Yeast functional assay of the p53 gene status in human cell lines maintained in our laboratory.

Fukaya K.-i., Ishioka C., Namba M.

Acta Med. Okayama 51:261-265(1997).

Persistence of hepatitis C virus RNA in established human hepatocellular carcinoma cell lines.

Kosaka T., Tsuji T., Namba M.

J. Med. Virol. 48:133-140(1996).

Establishment and characterization of a human hepatocellular carcinoma cell line JHH-7 producing alpha -fetoprotein and carcinoembryonic antigen -- changes in secretion of AFP and CEA from JHH-7 cells after heat treatment.

Shimizu K., Niiya M., Kameda H.

Hum. Cell 3:152-157(1990).

Integration of hepatitis B virus DNA into cells of six established human hepatocellular carcinoma cell lines.

Shimizu K., Niiya M., Kameda H., Fujita K., Ohno T.

Hepato-Gastroenterol. 37:457-460(1990).